Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
| ▸ | RXRB | P28702 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29715057 | 1.00 | CA2 (0.50) | CA2CA1TP53TSHRMAPT | |
| Formaldehyde SCHEMBL28314099 | 0.94 | CA1 (0.45) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL9588707 | 0.87 | CA1 (0.43) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL28785709 | 0.84 | ALDH1A1 (0.52) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL27470653 | 0.83 | ALDH1A1 (0.46) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL2092887 | 0.82 | CA2 (0.46) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL11002065 | 0.82 | TSHR (0.52) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL4654446 | 0.82 | RXRA (0.47) | CA2CA1MAPTGAARXRA | |
| SCHEMBL2094188 | 0.80 | MAPT (0.39) | CA2CA1TP53TSHRMAPT | |
| SCHEMBL6442084 | 0.80 | CA2 (0.45) | CA2CA1TP53TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1583 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12187911-B2 | Method for preparing water-soluble acrylic-modified phenolic-modified epoxy resin, water-soluble acrylic-modified phenolic-modified epoxy resin prepared thereby, and aqueous coating composition comprising same | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2025-01-07 | — | — | US | claimed |
| EP-4392414-A1 | INHIBITORS OF NLRP3 | PTC Therapeutics, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| US-20240158396-A1 | COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2024-05-16 | — | — | US | claimed |
| EP-4363406-A1 | NLRP3 INFLAMMASOME INHIBITORS | Astrazeneca AB (SE) | 2024-05-08 | — | — | EP | claimed |
| US-20240117213-A1 | METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME | SAMHWA PAINTS INDUSTRIES CO., LTD. (KR) | 2024-04-11 | — | — | US | claimed |
| WO-2023028534-A1 | INHIBITORS OF NLRP3 | PTC THERAPEUTICS, INC. (US) | 2023-03-02 | — | — | WO | claimed |
| WO-2023275366-A1 | NLRP3 INFLAMMASOME INHIBITORS | ASTRAZENECA AB (SE) | 2023-01-05 | — | — | WO | claimed |
| CN-111481989-B | Production trifluoromethyl (oxygen) formula filtration equipment is adjusted with multilayer to phenol | 内蒙古大中实业化工有限公司 | 2022-03-04 | — | — | CN | claimed |
| WO-2021075800-A1 | METHOD FOR PREPARING WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN, WATER-SOLUBLE ACRYLIC-MODIFIED PHENOLIC-MODIFIED EPOXY RESIN PREPARED THEREBY, AND AQUEOUS COATING COMPOSITION COMPRISING SAME | 삼화페인트공업주식회사 | 2021-04-22 | — | — | WO | claimed |
| CN-106565428-B | A kind of aphthacene organic semiconducting materials and preparation method thereof | 北京大学深圳研究生院 | 2019-11-26 | — | — | CN | claimed |
| CN-1041927-C | Dihalotriazolopyrimidine derivatives as fungicides | SHELL INT RESEARCH (NL) | 1999-02-03 | — | — | CN | claimed |
| CN-1193320-A | 1,3-oxa(thio) zine derivatives | BAYER AG (DE) | 1998-09-16 | — | — | CN | claimed |
| CN-1184405-A | Insecticidal N -(substituted arylmethyl) -4 -[bis (substituted phenyl or pyridyl) methyl] piperidines | FMC CORP (US) | 1998-06-10 | — | — | CN | claimed |
| CN-1153779-A | 2-(4-pyrazoloxy-pyrimidin-5-yl) acetic acid derivatives | SANDOZ LTD (CH) | 1997-07-09 | — | — | CN | claimed |
| CN-1147193-A | Insecticidal N-(substd. Arylmethyl)-4-[bis(substd. phenyl) methyl] piperidines | FMC CORP (US) | 1997-04-09 | — | — | CN | claimed |
| CN-1139434-A | Diazabicyclic neurokinin antagonists | PFIZER (US) | 1997-01-01 | — | — | CN | claimed |
| CN-1119015-A | Dihalotriazolopyrimidine derivatives as fungicides | SHELL INT RESEARCH (NL) | 1996-03-20 | — | — | CN | claimed |
| CN-1075144-A | Triazolopyrimidine derivatives | SHELL INT RESEARCH (NL) | 1993-08-11 | — | — | CN | claimed |
| EP-0054149-B1 | TRIFLUOROMETHOXYPHENYL-(DI)THIOPHOSPHORIC-ACID ESTERS, PROCESS FOR PREPARING THEM AND THEIR USE AS PESTICIDES | BASF Aktiengesellschaft (DE) | 1984-05-16 | — | — | EP | claimed |
| EP-0054149-A1 | Trifluoromethoxyphenyl-(di)thiophosphoric-acid esters, process for preparing them and their use as pesticides | BASF Aktiengesellschaft (DE) | 1982-06-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158396-A1 | COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF | NLRP3, NLRP1, PYCARD | CA2 4559/4885CA1 4796/4885TP53 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.